The airway goblet cell

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 1, 2003, Pages 1-6

  Rogers, Duncan F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Goblet cell hyperplasia; Mucin; Mucous hypersecretion; Mucus

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AEOL 10150C; ANTISENSE OLIGONUCLEOTIDE; BATIMASTAT; CHLORIDE CHANNEL; CYCLIC GMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; GEFITINIB; MARCKS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MUCIN; ODN 64; ODN 83; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE INHIBITOR; SURAMIN; TALNIFLUMATE; UNCLASSIFIED DRUG; [4 (4 BROMOPHENYLSULFONYLCARBAMOYL)BENZOYL]VALYLPROLINE N (2 METHYL 1 TRIFLUOROACETYLPROPYL)AMIDE;

AIRWAY; APOPTOSIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG TARGETING; ENZYME INHIBITION; EXOCYTOSIS; GOBLET CELL; HOMEOSTASIS; HUMAN; HYPERPLASIA; LUNG INJURY; MUCUS SECRETION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SECRETION;

ANIMALS; APOPTOSIS; EXOCYTOSIS; GOBLET CELLS; HUMANS; HYPERPLASIA; MUCINS; RESPIRATORY MUCOSA;

EID: 0037211934     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00083-3     Document Type: Short Survey

References (15)

1. Rogers D.F. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy. Monaldi Arch. Chest Dis. 55:2000;324-332.
2. Rogers D.F. Airway goblet cells: responsive and adaptable front-line defenders. Eur. Respir. J. 7:1994;1690-1706.
3. Davis C.W., Abdullah L.H. In vitro models for airways mucin secretion. Pulm. Pharmacol. Ther. 10:1997;145-155.
4. J.R. Davies, I. Carlstedt, Respiratory tract mucins. in: M. Salthe (Ed.), Cilia and Mucus: from Development to Respiratory Defense. Marcel-Dekker, New York, 2001, pp. 167-178.
5. Roger P., Gascard J.P., Bara J., de Montpreville V.T., Yeadon M., Brink C. ATP induced MUC5AC release from human airways in vitro. Mediators Inflamm. 9:2000;277-284.
6. Li Y., Martin L.D., Spizz G., Adler K.B. MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J. Biol. Chem. 276:2001;40982-40990.
7. Koch H., Hofmann K., Brose N. Definition of Munc13-homology-domains and characterization of a novel ubiquitously expressed Munc13 isoform. Biochem. J. 349:2000;247-253.
8. 2+. Nature. 395:1998;908-912.
9. Newman T.M., Robichaud A., Rogers D.F. Microanatomy of secretory granule release from guinea pig tracheal goblet cells. Am. J. Respir. Cell Mol. Biol. 15:1996;529-539.
10. Nadel J.A., Burgel P.R. The role of epidermal growth factor in mucus production. Curr. Opin. Pharmacol. 1:2001;254-258.
11. Rose M.C., Nickola T.J., Voynow J.A. Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am. J. Respir. Cell Mol. Biol. 25:2001;533-537.
12. Nakanishi A., Morita S., Iwashita H., Sagiya Y., Ashida Y., Shirafuji H., Fujisawa Y., Nishimura O., Fujino M. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5175-5180.
13. Tesfaigzi Y., Fischer M.J., Martin A.J., Seagrave J. Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L1210-L1217.
14. Takeyama K., Fahy J.V., Nadel J.A. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am. J. Respir. Crit. Care Med. 163:2001;511-516.
15. Toda M., Tulic M.K., Levitt R.C., Hamid Q. A calcium activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J. Allergy Clin. Immunol. 109:2002;246-250.